$39.77 -0.75 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - New York Stock Exchange, Inc.

Dec. 8, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Biotechs 'Round-Trip' Trump-Inspired Rally; FDA Appointment Key

    Investors Business Daily | Dec. 8, 2016 | 15:39PM EST
  2. Sanofi May Battle Johnson & Johnson For European Biotech Actelion

    Investors Business Daily | Dec. 6, 2016 | 12:01PM EST
  3. Stocks Futures Edge Higher; Cook: Apple Watch Doing Just Fine

    Investors Business Daily | Dec. 6, 2016 | 07:54AM EST
  4. Warren Buffett’s Only 3 Dividend Stocks with 4%+ Yields

    TalkMarkets | Nov. 28, 2016 | 16:45PM EST
  5. Lung Disease Stocks Advance After Actelion Approached By J&J

    TalkMarkets | Nov. 25, 2016 | 17:04PM EST
  6. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets | Nov. 18, 2016 | 08:30AM EST
  7. 5 Pharma Stocks In Focus On World Diabetes Day

    TalkMarkets | Nov. 14, 2016 | 13:21PM EST
  8. Sanofi (SNY) Beats Earnings, Revenues Rise Y/Y; Ups View

    TalkMarkets | Oct. 31, 2016 | 12:05PM EST
  9. Regeneron trading down on Sanofi news, says Piper Jaffray

    TalkMarkets | Oct. 28, 2016 | 13:28PM EST
  10. Clarifying Confusion Over Mylan's EpiPen Profits

    TalkMarkets | Oct. 9, 2016 | 01:27AM EST
  11. Biosimilars In Limelight On FDA Approval Of Amgen Drug

    TalkMarkets | Sep. 27, 2016 | 12:30PM EST
  12. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets | Sep. 26, 2016 | 12:20PM EST
  13. Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO

    TalkMarkets | Sep. 23, 2016 | 12:15PM EST
  14. Regeneron Stock Dips As Earnings Beat And Revenue Lags

    Investors Business Daily | Aug. 4, 2016 | 09:44AM EST
  15. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 11:20AM EST
  16. AbbVie, Merck Beat Earnings Estimates, But Sanofi Lags

    Investors Business Daily | Jul. 29, 2016 | 09:46AM EST
  17. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  18. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  19. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  20. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  21. Sanofi, Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology

    Benzinga | Jan. 11, 2016 | 05:25AM EST
  22. Sanofi, Warp Drive Bio to Collaborate on Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms

    Benzinga | Jan. 11, 2016 | 04:20AM EST
  23. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  24. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  25. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  26. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  27. MannKind Is Plummeting

    Benzinga | Jan. 5, 2016 | 09:19AM EST
  28. Why MannKind Could Be a Value Trap

    GuruFocus | Jan. 4, 2016 | 14:15PM EST
  29. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  30. Sanofi Announces Dengvaxia Dengue Vaccine Approved in Brazil

    Benzinga | Dec. 28, 2015 | 05:33AM EST
  31. Francis Chou's Holdings Trading at Low PE

    GuruFocus | Dec. 23, 2015 | 18:10PM EST
  32. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  33. Microsoft, Intel and National Oilwell Varco Have High Dividend Yields in Bill Nygren's Portfolio

    GuruFocus | Dec. 17, 2015 | 11:54AM EST
  34. Sanofi Enters Negotiations to Swap Merial for Boehringer Ingelheim's Consumer Healthcare Business

    Benzinga | Dec. 15, 2015 | 04:19AM EST
  35. Warren Buffett Further Pares Munich Re Stake

    GuruFocus | Dec. 14, 2015 | 16:52PM EST
  36. Warren Buffett Sells More Munich Re

    GuruFocus | Dec. 14, 2015 | 16:52PM EST
  37. Regeneron, Sanofi Announce UnitedHealth Group to Provide Preferred Access Praluent Injection

    Benzinga | Dec. 11, 2015 | 04:13AM EST
  38. Relypsa Stock Jumps On Buyout Rumors

    IBD | Dec. 4, 2015 | 15:31PM EST
  39. LinkedIn, Palo Alto, Regeneron Profit Estimates Rising

    IBD | Dec. 4, 2015 | 08:02AM EST
  40. U.S.-Traded Eurozone Stocks React Mildly To ECB Vote

    IBD | Dec. 3, 2015 | 18:11PM EST
  41. Sanofi chips at Biogen share

    IBD | Nov. 30, 2015 | 18:53PM EST
  42. Sanofi Chipping Away At Biogen's MS Dominance

    IBD | Nov. 30, 2015 | 11:32AM EST
  43. Must Watch Stocks for November 30, 2015

    Benzinga | Nov. 30, 2015 | 04:16AM EST
  44. Benzinga's Weekend M&A Chatter

    Benzinga | Nov. 29, 2015 | 19:44PM EST
  45. Bristol-Myers Looks Beyond Cancer To Build Portfolio

    IBD | Nov. 27, 2015 | 08:02AM EST
  46. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  47. Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolled

    Benzinga | Nov. 24, 2015 | 04:21AM EST
  48. CVS Makes Amgen New BFF

    IBD | Nov. 23, 2015 | 18:42PM EST
  49. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD | Nov. 23, 2015 | 16:06PM EST
  50. Weekly 3-Year Low Highlights: Sanofi, Exelon, Cummins, W.W. Grainger

    GuruFocus | Nov. 18, 2015 | 10:59AM EST
Trading Center